Molecule Information
General Information of the Molecule (ID: Mol01941)
| Name |
NPR2 like, GATOR1 complex subunit (NPRL2)
,Homo sapiens
|
||||
|---|---|---|---|---|---|
| Synonyms |
NPRL2; TUSC4
Click to Show/Hide
|
||||
| Molecule Type |
Protein
|
||||
| Gene Name |
NPRL2
|
||||
| Gene ID | |||||
| Location |
chr3:50,347,330-50,350,826[-]
|
||||
| Sequence |
MGSGCRIECIFFSEFHPTLGPKITYQVPEDFISRELFDTVQVYIITKPELQNKLITVTAM
EKKLIGCPVCIEHKKYSRNALLFNLGFVCDAQAKTCALEPIVKKLAGYLTTLELESSFVS MEESKQKLVPIMTILLEELNASGRCTLPIDESNTIHLKVIEQRPDPPVAQEYDVPVFTKD KEDFFNSQWDLTTQQILPYIDGFRHIQKISAEADVELNLVRIAIQNLLYYGVVTLVSILQ YSNVYCPTPKVQDLVDDKSLQEACLSYVTKQGHKRASLRDVFQLYCSLSPGTTVRDLIGR HPQQLQHVDERKLIQFGLMKNLIRRLQKYPVRVTREEQSHPARLYTGCHSYDEICCKTGM SYHELDERLENDPNIIICWK Click to Show/Hide
|
||||
| Function |
As a component of the GATOR1 complex functions as an inhibitor of the amino acid-sensing branch of the TORC1 pathway. The GATOR1 complex strongly increases GTP hydrolysis by RRAGA and RRAGB within RRAGC-containing heterodimers, thereby deactivating RRAGs, releasing mTORC1 from lysosomal surface and inhibiting mTORC1 signaling. The GATOR1 complex is negatively regulated by GATOR2 the other GATOR subcomplex in this amino acid-sensing branch of the TORC1 pathway.
Click to Show/Hide
|
||||
| Uniprot ID | |||||
| Ensembl ID | |||||
| HGNC ID | |||||
| Click to Show/Hide the Complete Species Lineage | |||||
Type(s) of Resistant Mechanism of This Molecule
Drug Resistance Data Categorized by Drug
Approved Drug(s)
1 drug(s) in total
| Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
|
|
||||
| Disease Class: Prostate hyperplasia | [1] | |||
| Resistant Disease | Prostate hyperplasia [ICD-11: GA90.0] | |||
| Resistant Drug | Everolimus | |||
| Molecule Alteration | Expression | Up-regulation |
||
| Experimental Note | Identified from the Human Clinical Data | |||
| Cell Pathway Regulation | mTOR signaling pathway | Inhibition | hsa04150 | |
| In Vitro Model | PC3 cells | Prostate | Homo sapiens (Human) | CVCL_0035 |
| RWPE-1 cells | Prostate | Homo sapiens (Human) | CVCL_3791 | |
| PCa LNCaP cells | Prostate | Homo sapiens (Human) | CVCL_D575 | |
| In Vivo Model | Balb/c athymic nude mouse xenograft model | Mus musculus | ||
| Experiment for Molecule Alteration |
Western blotting assay | |||
| Experiment for Drug Resistance |
CCK8 assay | |||
| Mechanism Description | NPRL2 enhances autophagy and the resistance to Everolimus in castration-resistant prostate cancer.NPRL2-silencing increased the activity of mTOR signaling, and the autophagy attenuation induced by NPRL2-silencing in EVS-treated CRPC cells was associated with the increase of apoptosis. | |||
References
visits since 2022
If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Zhang.
